A novel S-scheme heterojunction of Cd0.5Zn0.5S/BiOCl with oxygen defects for antibiotic norfloxacin photodegradation: Performance, mechanism, and intermediates toxicity evaluation was written by Cai, Mingjie;Liu, Yanping;Dong, Kexin;Wang, Chunchun;Li, Shijie. And the article was included in Journal of Colloid and Interface Science in 2023.Product Details of 70458-96-7 The following contents are mentioned in the article:
S-scheme heterojunction structure can endow the photocatalysts with high-performance photo-degradation of pharmaceuticals and personal care products (PPCPs) since it can remain the photogenerated electrons/holes with stronger redox ability. Herein, an integrative S-scheme heterojunction photocatalyst building from Cd0.5Zn0.5S nanoparticles and BiOCl microflowers with oxygen vacancies (OVs) was developed. Moreover, the in-situ grown process ensures the firm contact and intense electron coupling between BiOCl and Cd0.5Zn0.5S. As a result, Cd0.5Zn0.5S/BiOCl exhibited a significant reinforcement of photo-activity and stability for the abatement of antibiotic norfloxacin, manifesting a 2.8-fold or 9.6-fold enhancement compared to pristine Cd0.5Zn0.5S or BiOCl. Cd0.5Zn0.5S/BiOCl also shows good resistance to alk., sodium salts and humic acid. The performance of Cd0.5Zn0.5S/BiOCl to photocatalytically degrade other PPCPs with different mol. structures was further confirmed. At last, the ability of Cd0.5Zn0.5S/BiOCl for PPCPs de-toxicity was verified by evaluating the toxicity of norfloxacin and its degradation intermediate. This study demonstrates a new S-scheme heterojunction photocatalyt for efficient removal of PPCPs as well as provides some insights into developing high-performance metal sulfide solid-solution-based S-scheme heterojunctions for water decontamination. This study involved multiple reactions and reactants, such as 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid (cas: 70458-96-7Product Details of 70458-96-7).
1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid (cas: 70458-96-7) belongs to piperazine derivatives. Piperazine is a fairly basic compound and is an amine solvent. Two common salts in the form of which piperazine is usually prepared for pharmaceutical or veterinary purposes are the citrate, 3C4H10N2.2C6H8O7 (i.e. containing 3 molecules of piperazine to 2 molecules of citric acid), and the adipate, C4H10N2.C6H10O4 (containing 1 molecule each of piperazine and adipic acid).Product Details of 70458-96-7
Referemce:
Piperazine – Wikipedia,
Piperazines – an overview | ScienceDirect Topics